Michele Lussier

Title: Michele Lussier: Innovator in Meningococcal Vaccine Development

Introduction

Michele Lussier is a prominent inventor based in Augustin-des-Maures, CA. She has made significant contributions to the field of vaccine development, particularly in the area of meningococcal polysaccharide conjugate vaccines. With a total of 4 patents to her name, Lussier's work has the potential to impact public health significantly.

Latest Patents

Lussier's latest patents focus on chemically-modified group B polysaccharides. One of her inventions relates to vaccines that utilize these modified polysaccharides conjugated to a protein carrier. More specifically, her work includes novel group B meningococcal unsaturated N-acyl derivative polysaccharides and their conjugates. These pharmaceutical compositions comprise conjugate molecules of group B meningococcal unsaturated N-acyl derivative polysaccharide fragments covalently bound to proteins, which can be used as effective vaccines.

Career Highlights

Throughout her career, Michele Lussier has worked with esteemed organizations such as the National Research Council of Canada and Baxter International Inc. Her experience in these institutions has allowed her to develop innovative solutions in vaccine technology.

Collaborations

Lussier has collaborated with notable professionals in her field, including Harold J Jennings and Robert Pon. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Michele Lussier is a trailblazer in the development of meningococcal vaccines, with a focus on innovative polysaccharide conjugates. Her contributions to the field are invaluable and continue to pave the way for advancements in vaccine technology.